National campaign for rabies-free India by 2030 was launched at the 4th CII Life Sciences Conclave. As a part of the campaign to make India rabies-free by 2030, several activities
Cadila Pharma launches Belmore to treat uncontrolled LDL-cholesterol. High LDL cholesterol can lead to serious life-threatening heart complications due to blockage in blood vessels. More than 30 % of adults
Cadila Pharma leads in digital transformation. The digital transformation has added a new dimension to the healthcare industry as till a while ago, digital was seen as the future, but
Cadila pharma launches NuPTH , an osteoporosis biosimilar in India. The Forteo biosimilar is used for treatment of osteoporosis and in patients with increased risk of fracture. India is the Osteoporosis
Cadila pharma supports local communities, distributes essential kits to 1500 families living in difficult conditions and facing a hard time due to lockdown. June 5, 2020 Ahmedabad: With thousands of
